Latest News

New research shows that while niacin added to statin therapy increases HDL cholesterol levels it does not improve HDL functionality

While two large clinical trials recently showed that adding niacin to statin therapy failed to improve clinical outcomes despite a significant increase in HDL-C levels, little is known about exactly why the increased HDL-C levels did not reduce the risk of cardiovascular events, including heart attack and stroke. Now, a small study has shown that while niacin increased measured levels of HDL-C, it did not improve the functionality of HDL. This may provide an explanation for the failure of niacin to further reduce cardiovascular risk.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • How studying damage to prefrontal lobe has helped unlock the brain's mysteries

  • Breastfeeding study shows need for effective peer counseling programs

  • Socially-assistive robots help kids with autism learn by providing personalized prompts

  • After Great Recession, Americans are unhappy, worried, pessimistic, study finds

  • Cellphone addiction harming academic performance is 'an increasingly realistic possibility'

  • Assortativity signatures of transcription factor networks contribute to robustness

  • Antidepressants show potential for postoperative pain

  • Report advocates improved police training

  • Fear, safety and the role of sleep in human PTSD: Fragmented REM sleep may hinder effective treatment

  • Study reveals drivers of Western consumers' readiness to eat insects

  •